Dynatronics (NASDAQ:DYNT) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Dynatronics (NASDAQ:DYNTGet Free Report) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

Dynatronics Stock Performance

Dynatronics stock opened at $0.76 on Monday. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.83 and a quick ratio of 0.70. Dynatronics has a one year low of $0.72 and a one year high of $3.19. The stock has a market capitalization of $3.08 million, a PE ratio of -0.57 and a beta of 0.31. The business’s fifty day moving average is $0.79 and its 200 day moving average is $1.22.

Institutional Investors Weigh In On Dynatronics

A hedge fund recently bought a new stake in Dynatronics stock. Albion Financial Group UT bought a new stake in Dynatronics Co. (NASDAQ:DYNTFree Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 18,000 shares of the medical equipment provider’s stock, valued at approximately $26,000. Albion Financial Group UT owned 0.45% of Dynatronics as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 5.88% of the company’s stock.

About Dynatronics

(Get Free Report)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products; and therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes.

Further Reading

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.